MOLECULAR TEMPLATES, INC.

Analyst Reco. Molecular Templates, Inc.

Equities

MTEM

US6085502085

Market Closed - Nasdaq Other stock markets 03:59:51 2024-07-16 pm EDT			5-day change	1st Jan Change
1.39 ^USD	-1.42%		+3.73%	-62.73%

Jun. 03	Molecular Templates, Inc. Provides Interim Update	CI
May. 15	Earnings Flash (MTEM) MOLECULAR TEMPLATES Posts Q1 Revenue $11.1M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Adjusts Price Target on Molecular Templates to $1 From $4.50, Maintains Overweight Rating	22-11-11	MT
Stifel Nicolaus Adjusts Molecular Templates Price Target to $5 From $9, Maintains Buy Rating	22-08-12	MT
BofA Securities Downgrades Molecular Templates to Underperform From Buy, Sets Price Target at $1.50	22-05-27	MT
Stifel Adjusts Molecular Templates' Price Target to $9 From $11, Reiterates Buy Rating	22-05-16	MT
Barclays Adjusts Molecular Templates' Price Target to $4.50 from $8, Keeps Overweight Rating	22-03-30	MT
Oppenheimer Lowers Price Target for Molecular Templates to $9 From $13, Maintains Outperform Rating	21-12-01	MT
MOLECULAR TEMPLATES : UBS Adjusts PT on Molecular Templates to $8 From $13 on MT-3724 Discontinuation, TAK-169 Rights Reversion, MT-6402 Program Start; Neutral Rating Kept	21-07-30	MT
MOLECULAR TEMPLATES : BofA Securities Starts Molecular Templates at Buy with $12 Price Target	21-04-21	MT
MOLECULAR TEMPLATES : Oppenheimer Adjusts Molecular Templates' Price Target to $13 From $18, Maintains Outperform Rating	21-04-15	MT
MOLECULAR TEMPLATES : UBS Starts Molecular Templates at Neutral With $13 Price Target	21-02-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer